Tocilizumab for refractory morphea in adults: A case series

• Sarah Lonowski, MD, MBA,
• Nathaniel Goldman, BA,
• Bina Kassamali, BA,
• Neda Shahriari, MD,
• Avery LaChance, MD, MPH,
• Ruth Ann Vleugels, MD, MPH, MBA

Affiliations

Sarah Lonowski, MD, MBA

Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts

Nathaniel Goldman, BA

Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; New York Medical College, School of Medicine, Valhalla, New York

Bina Kassamali, BA

Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, School of Medicine, Boston, Massachusetts

Neda Shahriari, MD

Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts

Avery LaChance, MD, MPH

Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, School of Medicine, Boston, Massachusetts

Ruth Ann Vleugels, MD, MPH, MBA

Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, School of Medicine, Boston, Massachusetts; Correspondence to: Ruth Ann Vleugels, MD, MPH, MBA, Brigham and Women’s Hospital Department of Dermatology, Harvard Medical School, 221 Longwood Ave, Boston, MA 02115.